AU5072000A - Pharmaceutical composition for nasally administering water-soluble active substances - Google Patents

Pharmaceutical composition for nasally administering water-soluble active substances

Info

Publication number: AU5072000A
Authority: AU; Australia
Prior art keywords: pharmaceutical composition; active substances; soluble active; nasally administering; administering water
Prior art date: 1999-06-02
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU50720/00A

Inventor

Norbert Klocker

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Hexal AG

Original Assignee

Hexal AG

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-06-02

Filing date

2000-05-26

Publication date

2000-12-28

1999-06-02 Priority claimed from DE1999125289 external-priority patent/DE19925289A1/en

1999-08-03 Priority claimed from DE1999136545 external-priority patent/DE19936545A1/en

2000-05-26 Application filed by Hexal AG filed Critical Hexal AG

2000-12-28 Publication of AU5072000A publication Critical patent/AU5072000A/en

Status Abandoned legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Otolaryngology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Hospice & Palliative Care (AREA)
Biomedical Technology (AREA)
Epidemiology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AU50720/00A 1999-06-02 2000-05-26 Pharmaceutical composition for nasally administering water-soluble active substances Abandoned AU5072000A (en)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
DE19925289		1999-06-02
DE1999125289 DE19925289A1 (en)	1999-06-02	1999-06-02	Stable, well-tolerated composition for intranasal administration of water-soluble drugs, e.g. nicotine, comprising drug, neutral oil (preferably triglyceride) and optionally solubilizer
DE1999136545 DE19936545A1 (en)	1999-08-03	1999-08-03	Nasal pharmaceutical composition, useful e.g. for delivering corticosteroids, comprises at least one water-soluble active ingredient and a neutral oil e.g. a medium-chain fatty acid triglyceride or propylene glycol ester
DE19936545		1999-08-03
PCT/EP2000/004800 WO2000074652A1 (en)	1999-06-02	2000-05-26	Pharmaceutical composition for nasally administering water-soluble active substances

Publications (1)

Publication Number	Publication Date
AU5072000A true AU5072000A (en)	2000-12-28

Family

ID=26053615

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU50720/00A Abandoned AU5072000A (en)	1999-06-02	2000-05-26	Pharmaceutical composition for nasally administering water-soluble active substances

Country Status (4)

Country	Link
EP (1)	EP1189596A1 (en)
JP (1)	JP2005505491A (en)
AU (1)	AU5072000A (en)
WO (1)	WO2000074652A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20040191207A1 (en) *	2003-03-31	2004-09-30	Lipari John M.	Alpha-hydroxy acid ester drug delivery compositions and methods of use
FR2856302B1 (en) *	2003-06-20	2005-12-02	Anben Pharma	PHARMACEUTICAL COMPOSITION AS AN ANTI-INFECTIVE AGENT OF THE UPPER RESPIRATORY TRACT
GB2437488A (en) *	2006-04-25	2007-10-31	Optinose As	Pharmaceutical oily formulation for nasal or buccal administration
US9192570B2 (en)	2013-12-20	2015-11-24	AntiOP, Inc.	Intranasal naloxone compositions and methods of making and using same
US9561177B2 (en)	2014-03-14	2017-02-07	Adapt Pharma Limited	Nasal drug products and methods of their use
US9480644B2 (en)	2014-03-14	2016-11-01	Opiant Pharmaceuticals, Inc.	Nasal drug products and methods of their use
US10085937B2 (en)	2014-03-14	2018-10-02	Adapt Pharma Limited	Nasal drug products and methods of their use
CN106163499A (en)	2014-03-14	2016-11-23	欧皮安特制药有限公司	Nasal drug product and method of use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1222395B (en) *	1987-07-30	1990-09-05	Pierrel Spa	PHARMACEUTICAL COMPOSITION FOR INTRANASAL ADMINISTRATION INCLUDING THE HORMONE GHRH, A COLINERGIC AGONIST AND / OR A BILE SALT
DK0532546T3 (en) *	1990-05-10	1998-12-28	Nycomed Pharma As	Pharmaceutical preparation containing N-glycofurols and N-ethylene glycols
CA2050425A1 (en) *	1990-09-03	1992-03-04	Yoshiaki Uda	Pharmaceutical composition and its mucous use
US5955098A (en) *	1996-04-12	1999-09-21	Flemington Pharmaceutical Corp.	Buccal non polar spray or capsule

2000
- 2000-05-26 EP EP00935121A patent/EP1189596A1/en not_active Withdrawn
- 2000-05-26 WO PCT/EP2000/004800 patent/WO2000074652A1/en not_active Ceased
- 2000-05-26 JP JP2001501189A patent/JP2005505491A/en active Pending
- 2000-05-26 AU AU50720/00A patent/AU5072000A/en not_active Abandoned

Also Published As

Publication number	Publication date
JP2005505491A (en)	2005-02-24
EP1189596A1 (en)	2002-03-27
WO2000074652A1 (en)	2000-12-14

Similar Documents

Publication	Publication Date	Title
AU2331801A (en)	2001-07-09	Improved pharmaceutical compositions for poorly soluble drugs
PL351526A1 (en)	2003-05-05	Pharmaceutical formulation comprising amoxycillin
AU2879100A (en)	2000-08-29	Formulation and system for intra-oral delivery of pharmaceutical agents
AU4334700A (en)	2000-10-23	Pharmaceutical dosage form for pulsatile delivery of methylphenidate
AU7375598A (en)	1998-11-27	Stable oral pharmaceutical dosage forms
AU5326100A (en)	2000-12-28	Pharmaceutical compositions and methods for use
IL145559A0 (en)	2002-06-30	Tolperison-containing pharmaceutical preparation for oral administration
AU4328800A (en)	2000-11-10	Pharmaceutical formulation
ZA200308221B (en)	2004-09-29	Pharmaceutical compositions for oral and topical administration.
AU1887401A (en)	2001-06-25	Medicinal composition
AU7594900A (en)	2001-05-10	Pharmaceutical formulations containing poorly soluble drug substances
AU6715600A (en)	2001-03-19	Pharmaceutical formulations
AU5460800A (en)	2000-12-18	Pharmaceutical transdermal compositions
AU5072000A (en)	2000-12-28	Pharmaceutical composition for nasally administering water-soluble active substances
AU4977300A (en)	2000-11-17	Pharmaceutical formulations
AU1385801A (en)	2001-04-30	Pharmaceutical formulations
AU2001260089A1 (en)	2001-12-03	Pharmaceutical compositions comprising desglymidodrine as an active drug substance
AU3926000A (en)	2000-10-23	Methods and compositions for drug delivery
AU5415699A (en)	2000-02-28	Water-soluble pharmaceutical formulation for administering sildenafil
AU3839900A (en)	2000-11-10	Pharmaceutical formulation
GB9902227D0 (en)	1999-03-24	Pharmaceutical composition for topical administration
AU2882699A (en)	1999-09-15	Stabilizing composition for pharmaceutical dosage forms
AU1388501A (en)	2001-06-06	Pharmaceutical formulation
AU3860797A (en)	1999-02-10	Pharmaceutical formulations for oral administration
AU6473699A (en)	2000-05-22	Aqueous drug formulation for oral application

Legal Events

Date	Code	Title	Description
2002-04-11	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase